Human Xtensions Past Earnings Performance

Past criteria checks 0/6

Human Xtensions's earnings have been declining at an average annual rate of -5.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been declining at an average rate of 36.1% per year.

Key information

-5.3%

Earnings growth rate

57.7%

EPS growth rate

Medical Equipment Industry Growth15.2%
Revenue growth rate-36.1%
Return on equity-116.1%
Net Margin-838.3%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?

Aug 12
Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?

Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?

Mar 25
Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Human Xtensions' (TLV:HUMX) Cash Burn Situation

Oct 21
Here's Why We're Not Too Worried About Human Xtensions' (TLV:HUMX) Cash Burn Situation

We Think Human Xtensions (TLV:HUMX) Can Afford To Drive Business Growth

May 03
We Think Human Xtensions (TLV:HUMX) Can Afford To Drive Business Growth

What Type Of Shareholders Own The Most Number of Human Xtensions Ltd. (TLV:HUMX) Shares?

Mar 03
What Type Of Shareholders Own The Most Number of Human Xtensions Ltd. (TLV:HUMX) Shares?

Revenue & Expenses Breakdown
Beta

How Human Xtensions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TASE:HUMX Revenue, expenses and earnings (ILS Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 235-391923
30 Jun 235-432025
31 Mar 235-421927
31 Dec 223-451829
30 Sep 223-471831
30 Jun 223-491931
31 Mar 223-542233
31 Dec 213-542233
30 Sep 213-532132
30 Jun 213-451728
31 Mar 2112-351326
31 Dec 2021-291127
30 Sep 2026-31934
30 Jun 2031-401044
31 Mar 2022-451044
31 Dec 1912-491043

Quality Earnings: HUMX is currently unprofitable.

Growing Profit Margin: HUMX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HUMX is unprofitable, and losses have increased over the past 5 years at a rate of 5.3% per year.

Accelerating Growth: Unable to compare HUMX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HUMX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.5%).


Return on Equity

High ROE: HUMX has a negative Return on Equity (-116.15%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.